gemcitabine has been researched along with linoleic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, Q; Gao, SY; Tao, XM; Wang, JB; Wang, JC; Zhang, LR; Zhang, Q | 1 |
| Gui, W; Han, Q; Li, W; Liu, C; Liu, H; Yang, X; Zhu, C | 1 |
2 other study(ies) available for gemcitabine and linoleic acid
| Article | Year |
|---|---|
Enhanced anticancer activity of gemcitabine coupling with conjugated linoleic acid against human breast cancer in vitro and in vivo.
Topics: Animals; Antineoplastic Agents; Biological Availability; Breast Neoplasms; Cell Line, Tumor; Cell Membrane; Cell Survival; Deoxycytidine; Drug Stability; Female; Gemcitabine; Half-Life; Humans; Linoleic Acid; MCF-7 Cells; Mice; Mice, Inbred BALB C; Mice, Nude; Nucleoside Transport Proteins; Prodrugs; Rats; Rats, Sprague-Dawley | 2012 |
Precise engineering of Gemcitabine prodrug cocktails into single polymeric nanoparticles delivery for metastatic thyroid cancer cells.
Topics: Adenocarcinoma, Follicular; Apoptosis; Cell Line, Tumor; Deoxycytidine; Drug Carriers; Gemcitabine; Humans; Linoleic Acid; Microscopy, Electron; Nanoconjugates; Nanoparticles; Polymers; Prodrugs; Thyroid Cancer, Papillary; Thyroid Neoplasms | 2020 |